Priority Date: 12.12.13 (US 201361915215P)

DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF THE CRISPR-CAS SYSTEMS AND COMPOSITIONS FOR TARGETING DISORDERS AND DISEASES USING PARTICLE DELIVERY COMPONENTS

  • Application ID: EP18199415
  • Status: Request for examination was made

Applicants

Research organisation logo small
Research Organisation

Attorney

operating since 1887
1450.57
Headquarter in London and 20 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 175 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 12.12.2013 - Priority Date (US 201361915215P)
  • 17.04.2019 - Publication A1 (EP3470089)